Health Discovery (HDVY) Stock Price, News & Analysis

Company Overview

Health Discovery Corporation operates as a pattern recognition company that uses mathematical techniques to analyze data to uncover patterns primarily in the field of molecular diagnostics in the United States. Its intellectual property includes Support Vector Machines (SVM), which are mathematical algorithms; and biomarkers that are biological indicators or genetic expression signatures of certain disease states, as well as Fractal Genomic Modeling technology. The company was incorporated in 2001 and is based in Atlanta, Georgia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 25,700 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

HDVY Stock Analysis - Frequently Asked Questions

How were Health Discovery's earnings last quarter?

Health Discovery Corp. (OTCMKTS:HDVY) issued its earnings results on Tuesday, June, 30th. The company reported $0.00 earnings per share (EPS) for the quarter.

How do I buy shares of Health Discovery?

Shares of HDVY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Health Discovery own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Health Discovery investors own include Ford Motor (F), Ericsson (ERIC), Hydrofarm Holdings Group (HYFM), Intel (INTC), JD.com (JD), Lucid Group (LCID) and Uranium Energy (UEC).

Company Calendar

• Last Earnings: 6/30/2020
• Today: 7/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Trading
• Current Symbol: OTCMKTS:HDVY
• CIK: 1141788
• Web: www.healthdiscoverycorp.com
• Phone: (404) 566-4865
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 420,330,000
• Free Float: 284,986,000
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 1.24